Aktis Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	371.63	37.78	37.16	29.51	128.6
Short-Term Investments	166.85	189	260.01	68.35	-
Cash & Short-Term Investments	538.48	226.79	297.17	97.86	128.6
Cash Growth	72.36%	-23.68%	203.66%	-23.90%	-
Other Current Assets	5.46	3.52	3.69	2.34	3.88
Total Current Assets	543.94	230.31	300.85	100.2	132.48
Net Property, Plant & Equipment	28.11	27.25	20.87	20.92	4.87
Other Long-Term Assets	4.75	7.33	4.46	1.23	0.98
Total Assets	576.8	264.89	326.18	122.36	138.32
Accounts Payable	1.23	1.74	1.92	0.96	0.49
Accrued Expenses	6.3	9.52	6.33	3.75	3.93
Current Portion of Leases	1.43	1.32	1.3	1.53	0.85
Unearned Revenue	18.96	18.66	9.28	-	-
Total Current Liabilities	27.91	31.24	18.82	6.24	5.28
Long-Term Leases	10.15	10.23	10.71	11.87	0.92
Other Long-Term Liabilities	32.63	36.16	51.04	0.5	1.31
Total Long-Term Liabilities	42.78	46.39	61.75	12.37	2.23
Total Liabilities	70.69	77.63	80.58	18.61	7.5
Common Stock	0.01	-	-	-	-
Additional Paid-in Capital	681.23	10.37	4.91	2.47	0.98
Accumulated Other Comprehensive Income	-0.24	0.04	0.12	0.08	-
Retained Earnings	-174.89	-156.56	-92.83	-48.85	-20.21
Total Common Shareholders' Equity	506.11	-146.15	-87.8	-46.31	-19.23
Minority Interest	-	333.41	333.41	150.05	150.05
Shareholders' Equity	506.11	187.26	245.61	103.74	130.82
Total Liabilities & Equity	576.8	264.89	326.18	122.36	138.32
Total Debt	11.58	11.55	12.01	13.4	1.78
Net Cash (Debt)	526.91	215.24	285.16	84.46	126.82
Net Cash Growth	144.80%	-24.52%	237.63%	-33.40%	-
Net Cash Per Share	9.53	264.58	404.96	137.29	245.11
Book Value	506.11	-146.15	-87.8	-46.31	-19.23
Book Value Per Share	9.16	-179.65	-124.69	-75.27	-37.17
Tangible Book Value	506.11	-146.15	-87.8	-46.31	-19.23
Tangible Book Value Per Share	9.16	-179.65	-124.69	-75.27	-37.17

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q